Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2017; 7(11):2965-2967. doi:10.7150/thno.21603 This issue Cite

Editorial

New Kid on the Block

Thomas Reinheckel✉

Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University Freiburg, and German Cancer Consortium (DKTK), Partner site Freiburg, Freiburg, Germany

✉ Corresponding author: Tel: +49 761 203 9606. Email: thomas.reinheckeluni-freiburg.de

Citation:
Reinheckel T. New Kid on the Block. Theranostics 2017; 7(11):2965-2967. doi:10.7150/thno.21603. https://www.thno.org/v07p2965.htm
Other styles

File import instruction

Abstract

Cysteine cathepsins are a group of proteases involved in many physiological and pathological processes. Yet, the selective detection and inhibition of individual cathepsins is still challenging. This editorial is discussing the context of a recent work introducing a designed ankyrin repeat protein (DARPin) as novel approach for selective targeting of the protease cathepsin B.

Keywords: Cathepsin B, DARPin, protease inhibition, protease imaging

Citation styles

APA
Reinheckel, T. (2017). New Kid on the Block. Theranostics, 7(11), 2965-2967. https://doi.org/10.7150/thno.21603.

ACS
Reinheckel, T. New Kid on the Block. Theranostics 2017, 7 (11), 2965-2967. DOI: 10.7150/thno.21603.

NLM
Reinheckel T. New Kid on the Block. Theranostics 2017; 7(11):2965-2967. doi:10.7150/thno.21603. https://www.thno.org/v07p2965.htm

CSE
Reinheckel T. 2017. New Kid on the Block. Theranostics. 7(11):2965-2967.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use